Rosa v. City of Issaquah

District Court, W.D. Washington·Decided September 25, 2025·No. 2:24-cv-01673·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON CHEYANNE [DIXSON] ROSA, CASE NO. 2:24-cv-01673-TL Plaintiff, ORDER ON MOTION FOR v. SUMMARY JUDGMENT CITY OF ISSAQUAH, a municipal corporation in and for the State of Washington, Defendant.

This case arises out of Plaintiff’s request for accommodation for her religious objections to Defendant’s COVID-19 vaccination mandate. The matter is before the Court on Defendant’s Motion for Summary Judgment (Dkt. No. 14). Having considered the motion, Plaintiff’s Response (Dkt. No. 24), Defendant’s Reply (Dkt. No. 32), the relevant record, and having held oral argument on August 28, 2025, the Court GRANTS Defendant’s motion for summary judgment. The following facts either are not genuinely disputed or are taken in the light most favorable to Plaintiff, the non-moving party. A. The COVID-19 Pandemic in Washington1

On January 20, 2020, Western Washington took center stage in an evolving national and international crisis as the site of North America’s first known case of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.2 Dkt. No. 16 (Lynch Decl.) at 4 ¶¶ 7–8. By the end of that month, both the World Health Organization and then-U.S. Health and Human Services Secretary Alex M. Azar II had officially declared the COVID-19 pandemic a public health emergency by the. Id. at 6 ¶ 10. In Washington and around the world, daily life quickly turned upside down. By March 2020, the virus’s “rampant spread” had compelled federal, state, and local governments to take such “drastic actions” as “institut[ing] ‘stay home’ orders” and “implement[ing] widespread ‘social distancing measures.’” Pimentel-Estrada v. Barr, 458 F. Supp. 3d 1226, 1233 (W.D. Wash. 2020).

COVID-19 is an infectious disease that spreads easily from person to person through tiny droplets called aerosols, which are produced when a person exhales, coughs, sneezes, or talks and which can linger in indoor spaces like cigarette smoke. Id. at 4 ¶¶ 7–8, 29 ¶ 68. People who contract COVID-19 can spread the virus before they have symptoms. Id. at 4 ¶ 8. Some people never develop any symptoms (i.e., asymptomatic infection) but can still spread the virus, potentially without knowing that they were ever infected. Id. Individuals who do develop

1 Much of the factual background in this subsection is provided by Defendant’s expert, Dr. John Lynch. However, these are facts that Plaintiff either does not refute, or has not produced evidence to contradict. Plaintiff’s own expert, Dr. Harvey Risch, has not provided a similar factual background about the COVID-19 pandemic, the symptoms of COVID-19, or the development of COVID-19 vaccines. See generally Dkt Nos. 27, 27-1, 27-2. Dr. Risch does not appear to refute the accuracy of any fact in this section, though at times he disputes their significance. See Dkt. No. 27-1 at 15–30. 2 For simplicity, the Court refers in this order to both the SARS-CoV-2 virus and the disease it causes as “COVID-19.” symptoms may undergo a range of experiences, from mild or moderate symptoms, to severe symptoms requiring hospitalization, to death. Id. Some patients who do recover from acute COVID-19 infection are nonetheless left disabled by chronic illness colloquially referred to as “long Covid.” Id. at 5 ¶ 8. COVID-19 hospitalization in the United States peaked in January

2021, when 21 out of every 100,000 people in the country were in the hospital at one time. Id. at 7 ¶ 12. Certain populations were particularly hard hit by the pandemic and were more likely to experience hospitalization and death from COVID-19. Id. These included people over 65, communities of color, people with disabilities and medical conditions, and people experiencing poverty, incarceration, or other systemic inequalities. Id. Some patients who do recover from acute COVID-19 infection are left disabled by chronic illness colloquially referred to as “long Covid.” Id. at 5 ¶ 8. The staggeringly aggressive spread of the virus and its grave human cost precipitated a dramatic public health response. Scientists began working to develop vaccines against COVID-19 in January 2020. Id. at 8 ¶ 14. There was a broad consensus in the public health

community that an effective vaccination would be the key to emerging from the deep disruption caused by pre-vaccine mitigation measures such as lockdown orders. Id. at 7 ¶ 13. The first vaccines were granted emergency-use authorization by the Food and Drug Administration (“FDA”) in December 2020. Id. at 8 ¶ 15. After promising results, the first of these was approved by the FDA for adult use in August 2021. Id. at 10 ¶ 22, 12 ¶ 27. This was the Pfizer vaccine, which had been shown in lab trials to prevent 95% of confirmed COVID-19 cases. Id. at 10 ¶ 22, 12 ¶ 27. Although a vaccinated individual may still contract COVID-19 (experiencing what is known as a “breakthrough infections”), vaccines are associated with a greatly reduced risk of

severe illness or death. Id. at 18 ¶ 43, 134 ¶ 34(b) (Lynch rebuttal). A May 2021 study of healthcare workers in Israel showed not only that the infection rate was much lower among those who were vaccinated, but also that most vaccinated people who became infected were asymptomatic, while most unvaccinated people who became infected developed symptoms. Id. at 33 ¶ 76. Breakthrough infections in vaccinated people are also less likely to be passed along to

others than infections in unvaccinated people. Id. at 134 ¶ 34(b). Vaccination was able not only to save lives, but to slow the spread of infection, protect vulnerable populations, and reduce strain on healthcare systems over-taxed by COVID-19 hospitalizations. Id. at 14 ¶ 33. After the COVID-19 virus was first discovered in December 2019, it continued to evolve into new and more contagious variants. In the summer of 2021, the so-called Delta variant of COVID-19 (“Delta”) was surging in Washington and elsewhere in the United States. Id. at 25 ¶ 61. Delta was more than twice as contagious as earlier variants. Id. at 26 ¶ 62. Data at the time also showed that Delta caused longer infections and more serious illness than previous variants. Id. at 26 ¶ 63. As of July 30, 2021, the Washington Department of Health estimated that 1 in 172 Washingtonians had an active COVID-19 infection. Id. at 25 ¶ 62. One week later, that

proportion had increased to 1 in 156. Id. COVID-19 hospitalizations in the state were at an all- time high that summer and fall, and 95% of hospitalized patients were unvaccinated. Id. Vaccines available at the time showed efficacy against the Delta variant slightly below 90%. Id. at 26 ¶ 62. King County data from late 2021 showed that unvaccinated individuals were 4.5 times more likely than fully vaccinated individuals to test positive for COVID-19, 32 times more likely to be hospitalized, and 40 times more likely to die. Id. at 25 ¶ 62. On August 9, 2021, Washington Governor Jay Inslee issued the first version of a proclamation that would prohibit most state employees and Washington healthcare workers from working after October 18, 2021, without being fully vaccinated against COVID-19. See Dkt.

No. 15 (Johnson Decl. and exhibits) at 9–17 (Proclamation 21-14); Dkt. No. 16 at 24 ¶ 58. County and city governments quickly followed suit, establishing vaccination requirements for their employees. Dkt. No. 16 at 24 ¶¶ 59–60. By that time, vaccines had been shown to be safe and highly effective at preventing severe illness caused by COVID-19, and they remained so against the highly infectious Omicron variant that was surging by the end of 2021. Id. at 27–28

Free access — add to your briefcase to read the full text and ask questions with AI

Rosa v. City of Issaquah, (W.D. Wash. 2025).

Rosa v. City of Issaquah (Rosa v. City of Issaquah) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Cleveland Board of Education v. Loudermill
470 U.S. 532 (Supreme Court, 1985)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. National Wildlife Federation
497 U.S. 871 (Supreme Court, 1990)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Cisneros v. Alpine Ridge Group
508 U.S. 10 (Supreme Court, 1993)
Gonzaga University v. Doe
536 U.S. 273 (Supreme Court, 2002)
Ricci v. DeStefano
557 U.S. 557 (Supreme Court, 2009)
In Re Oracle Corp. Securities Litigation
627 F.3d 376 (Ninth Circuit, 2010)
Rea v. Matteucci
121 F.3d 483 (Ninth Circuit, 1997)
People of Guam v. Benny Toves Guerrero
290 F.3d 1210 (Ninth Circuit, 2002)
Leyden v. Citicorp Industrial Bank
782 P.2d 6 (Supreme Court of Colorado, 1989)
Dicomes v. State
782 P.2d 1002 (Washington Supreme Court, 1989)
Marable v. Nitchman
511 F.3d 924 (Ninth Circuit, 2007)